Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Various antigens/pathogens is a broad classification used to describe a diverse group of biological entities that trigger an immune response or cause disease. This category encompasses viral, bacterial, fungal, and parasitic components, as well as tumor-specific proteins that serve as targets for vaccines and immunotherapies (Janeway et al., 2001). Antigens are molecular structures, often proteins or polysaccharides, that are recognized by antibodies or T-cell receptors, while pathogens are the organisms that carry these structures (Alberts et al., 2002). In a therapeutic context, this term is often used for broad-spectrum anti-infectives or polyvalent vaccines that do not target a single human protein but rather a variety of foreign or abnormal targets (WHO, 2023). Drugs interacting with these entities include antibiotics that disrupt microbial cell walls and monoclonal antibodies that neutralize specific viral proteins (NIH, 2024). Because it represents a collective group rather than a single molecular entity, it is frequently used in clinical databases to denote treatments with multi-target or broad-spectrum activity.
Drugs targeting this category work through diverse mechanisms including direct lysis of pathogens, inhibition of microbial metabolic pathways (e.g., cell wall synthesis, protein synthesis), and the stimulation of adaptive immune memory against specific molecular patterns (StatPearls, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Various antigens/pathogens.